By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Henry Schein, Inc.

Henry Schein, Inc. (HSIC)

NASDAQ Currency in USD
$345.00
-$0.50
-0.15%
Last Update: 18 Jul 2026, 15:15
$41.68bn
Market Cap
104.23
P/E Ratio (TTM)
Forward Dividend Yield
$242.64-$442.82
52 Week Range

HSIC Stock Price Chart

Explore Henry Schein, Inc. interactive price chart. Choose custom timeframes to analyze HSIC price movements and trends.

HSIC Company Profile

Discover essential business fundamentals and corporate details for Henry Schein, Inc. (HSIC) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Distribution

IPO Date

3 Nov 1995

Employees

25.00k

CEO

Andrea Albertini

Description

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

HSIC Financial Timeline

Browse a chronological timeline of Henry Schein, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 4 Aug 2026

EPS estimate is $1.22, while revenue estimate is $3.37bn.

Earnings released on 5 May 2026

EPS came in at $1.32 surpassing the estimated $1.20 by +10.00%, while revenue for the quarter reached $3.37bn , beating expectations by +0.77%.

Earnings released on 24 Feb 2026

EPS came in at $1.34 surpassing the estimated $1.30 by +3.08%, while revenue for the quarter reached $3.44bn , beating expectations by +2.69%.

Earnings released on 4 Nov 2025

EPS came in at $1.38 surpassing the estimated $1.27 by +8.66%, while revenue for the quarter reached $3.34bn , missing expectations by -0.17%.

Earnings released on 5 Aug 2025

EPS came in at $1.10 falling short of the estimated $1.18 by -6.78%, while revenue for the quarter reached $3.24bn , missing expectations by -1.09%.

Earnings released on 5 May 2025

EPS came in at $1.15 surpassing the estimated $1.11 by +3.60%, while revenue for the quarter reached $3.17bn , missing expectations by -1.51%.

Earnings released on 25 Feb 2025

EPS came in at $1.19 falling short of the estimated $1.23 by -3.25%, while revenue for the quarter reached $3.19bn , missing expectations by -3.14%.

Earnings released on 5 Nov 2024

EPS came in at $1.22 surpassing the estimated $1.16 by +5.17%, while revenue for the quarter reached $3.17bn , missing expectations by -5.60%.

Earnings released on 6 Aug 2024

EPS came in at $1.23 surpassing the estimated $1.22 by +0.82%, while revenue for the quarter reached $3.14bn , missing expectations by -4.36%.

Earnings released on 7 May 2024

EPS came in at $1.10 surpassing the estimated $1.02 by +7.84%, while revenue for the quarter reached $3.17bn , missing expectations by -1.05%.

Earnings released on 27 Feb 2024

EPS came in at $0.66 falling short of the estimated $0.70 by -5.71%, while revenue for the quarter reached $3.02bn , missing expectations by -0.63%.

Earnings released on 13 Nov 2023

EPS came in at $1.32 matching the estimated $1.32, while revenue for the quarter reached $3.16bn , missing expectations by -1.84%.

Earnings released on 7 Aug 2023

EPS came in at $1.31 surpassing the estimated $1.28 by +2.34%, while revenue for the quarter reached $3.10bn , missing expectations by -0.84%.

Earnings released on 9 May 2023

EPS came in at $1.21 falling short of the estimated $1.24 by -2.42%, while revenue for the quarter reached $3.06bn , missing expectations by -0.97%.

Earnings released on 16 Feb 2023

EPS came in at $1.21 matching the estimated $1.21, while revenue for the quarter reached $3.37bn , beating expectations by +0.50%.

Earnings released on 1 Nov 2022

EPS came in at $1.09 falling short of the estimated $1.14 by -4.39%, while revenue for the quarter reached $3.07bn , missing expectations by -3.86%.

Earnings released on 2 Aug 2022

EPS came in at $1.16 matching the estimated $1.16, while revenue for the quarter reached $3.03bn , missing expectations by -2.92%.

Earnings released on 3 May 2022

EPS came in at $1.30 surpassing the estimated $1.19 by +9.24%, while revenue for the quarter reached $3.18bn , beating expectations by +2.47%.

Earnings released on 15 Feb 2022

EPS came in at $1.07 surpassing the estimated $0.91 by +17.58%, while revenue for the quarter reached $3.33bn , beating expectations by +5.61%.

Earnings released on 2 Nov 2021

EPS came in at $1.10 surpassing the estimated $0.95 by +15.79%, while revenue for the quarter reached $3.18bn , beating expectations by +8.51%.

Earnings released on 3 Aug 2021

EPS came in at $1.11 surpassing the estimated $0.97 by +14.43%, while revenue for the quarter reached $2.97bn , beating expectations by +3.34%.

HSIC Stock Performance

Access detailed HSIC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run